doi: 10.31128/AJGP-COVID-51-3.
COVID-19-related anosmia
Affiliations
- PMID: 35393605
- DOI: 10.31128/AJGP-COVID-51-3
Item in Clipboard
COVID-19-related anosmia
Aust J Gen Pract.
.
Abstract
On average, 47% of patients with COVID-19 self-report an olfactory disorder, although the inaccuracy of self-reporting means this figure may be higher.
Similar articles
-
Olfactory disorder in patients infected with SARS-CoV-2.J Microbiol Immunol Infect. 2021 Oct;54(5):992-996. doi: 10.1016/j.jmii.2020.08.010. Epub 2020 Aug 20. J Microbiol Immunol Infect. 2021. PMID: 32859529 Free PMC article.
-
[Loss of smell, a preliminary indicator of COVID-19].Rev Med Inst Mex Seguro Soc. 2021 Feb 2;59(1):4-6. doi: 10.24875/RMIMSS.M21000046. Rev Med Inst Mex Seguro Soc. 2021. PMID: 33666408 Spanish.
-
COVID-19 and Parkinson's disease: Defects in neurogenesis as the potential cause of olfactory system impairments and anosmia.J Chem Neuroanat. 2021 Sep;115:101965. doi: 10.1016/j.jchemneu.2021.101965. Epub 2021 May 11. J Chem Neuroanat. 2021. PMID: 33989761 Free PMC article. Review.
-
COVID-19 patient with recurrent anosmia and its impact on management.Eur Ann Otorhinolaryngol Head Neck Dis. 2022 Mar;139(2):115-116. doi: 10.1016/j.anorl.2021.07.009. Epub 2021 Aug 28. Eur Ann Otorhinolaryngol Head Neck Dis. 2022. PMID: 34481758 Free PMC article. No abstract available.
-
Olfactory training for olfactory dysfunction in COVID-19: A promising mitigation amidst looming neurocognitive sequelae of the pandemic.Clin Exp Pharmacol Physiol. 2022 Apr;49(4):462-473. doi: 10.1111/1440-1681.13626. Epub 2022 Feb 10. Clin Exp Pharmacol Physiol. 2022. PMID: 35090056 Review.
MeSH terms
LinkOut - more resources
Medical